Intervention

Artificial Intelligence

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common conditions7

Lead sponsors shown3

Clinical trials

3 shown

Chinese PE Multimodality Imaging Artificial Intelligence StudyNCT06526468 · 2010-09-01

RECRUITING

Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung CancerNCT06496360 · 2024-08-01

UNKNOWN

Implementation of an Integrated System of Artificial Intelligence and Referral Tracking for Real-time Diabetic Retinopathy ScreeningNCT05166122 · 2022-01-01

UNKNOWN

Common conditions

Artificial Intelligence1 Chronic Thromboembolic Pulmonary Disease1 Chronic Thromboembolic Pulmonary Hypertension1 Diabetic Retinopathy1 Non-small Cell Lung Cancer1 Pulmonary Embolism1 Screening1

Leading sponsors

China-Japan Friendship Hospital 1 Department of Medical Services Ministry of Public Health of Thailand 1 Qilu Hospital of Shandong University 1

Trial status mix

UNKNOWN2

RECRUITING1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.